Alignment Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alignment Healthcare (ALHC).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

10Buy

1Hold

Consensus RatingOverweight# Analysts11Avg. Consensus PT$20Upside to Avg. PT+156.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 4, 2026	JP Morgan	John Stansel	PT Cut	Overweight	$26→$22
Aug 3, 2026	Raymond James	John Ransom	Downgrade	Strong Buy→Outperform	$22→$19
May 26, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$19→$16
May 1, 2026	UBS	Jonathan Yong	PT Raise	Neutral	$21→$22
May 1, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$18→$19
Feb 5, 2026	JP Morgan	John Stansel	PT Raise	Overweight	$23→$26
Jan 16, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$19→$25
Jan 14, 2026	UBS	Kevin Caliendo	PT Raise	Neutral	$18→$21
Jan 6, 2026	Piper Sandler	Jessica Tassan	PT Raise	Overweight	$20→$30
Dec 17, 2025	JP Morgan	Lisa Gill	PT Raise	Overweight	$20→$23
Nov 24, 2025	JP Morgan	John Stansel	Upgrade	Neutral→Overweight	$18→$20
Nov 5, 2025	JP Morgan	Lisa Gill	PT Raise	Neutral	$17→$18
Nov 3, 2025	Barclays	Andrew Mok	PT Raise	Equal-Weight	$13→$18
Oct 31, 2025	UBS	Kevin Caliendo	PT Raise	Neutral	$17→$18
Oct 14, 2025	Goldman Sachs	Scott Fidel	Initiate	Buy	$21
Aug 25, 2025	Keybanc	Matthew Gillmor	Upgrade	Sector Weight→Overweight	$21
Jul 31, 2025	Barclays	Andrew Mok	Upgrade	Underweight→Equal-Weight	$9→$13
May 2, 2025	UBS	Kevin Caliendo	PT Raise	Neutral	$16→$17
Apr 15, 2025	Baird	Michael Ha	PT Raise	Outperform	$17→$22
Apr 8, 2025	Stifel	Craig Jones	PT Raise	Buy	$18→$23

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $26 to $22.

Benzinga Newsdesk

PRO
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $21 to $22.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $19

Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and raises the price target from $18 to $19.

Benzinga Newsdesk

6 Analysts Have This To Say About Alignment Healthcare

Benzinga Insights

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $26

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and raises the price target from $23 to $26.

Benzinga Newsdesk

Alignment Healthcare Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Alignment Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

PRO
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

PRO
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

PRO
Barclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $19

6 Analysts Have This To Say About Alignment Healthcare

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $26

People Also Watch

People Also Watch

Alignment Healthcare Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Alignment Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

PRORaymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

PROUBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

PROBarclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $19

6 Analysts Have This To Say About Alignment Healthcare

PROJP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $26

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

PRO
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

PRO
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

PRO
Barclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $19

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $26